Soliqua 100 IU/ml Insulin Glargine Plus 50mcg/ml Lixisenatide Pre-Filled Solution Pen for Injection

BRAND NAME: Soliqua 100/33 ABOUT THE PRODUCT: Soliqua 100/33 is a sophisticated, once-daily injectable treatment designed to simplify the management of type 2 diabetes. By combining two powerful medications—insulin glargine and lixisenatide—into one convenient SoloStar pre-filled pen, it helps adults achieve better glycemic control through a streamlined, easy-to-use routine. This dual-action approach works alongside diet and exercise to help you maintain stable blood glucose levels, offering a more efficient way to support your long-term health goals. BENEFITS & KEY FEATURES: **Simplified Daily Routine:** By combining basal insulin and a GLP-1 receptor agonist in a single pen, you reduce the number of daily injections required for your treatment plan. **Precision Dosing:** The SoloStar pen is designed for accuracy, allowing for 1-unit increments to ensure you receive the exact amount of medication required for your individual metabolic needs. **Improved Glycemic Control:** The synergistic effect of the two ingredients helps you reach your fasting plasma glucose targets more effectively than using either component alone. HOW TO USE SAFELY: **Directions:** Soliqua 100/33 is administered once daily via injection. Your starting dose will be determined by your healthcare provider based on your current treatment history. The dose should be titrated weekly by 2-4 units under medical supervision until your target glucose levels are reached. Never exceed the maximum dose of 60 units. Always inject into the recommended sites as instructed by your doctor and rotate your injection area to prevent skin complications. **Important Tips:** Never share your pen with others to avoid the risk of blood-borne infections. Always verify your dose on the pen display before injecting. If you are taking other oral medications, check with your physician regarding the timing of your doses, as this medication may affect how quickly other drugs are absorbed. Store your pens in a cool, safe place and always use a new needle for every injection. SAFETY NOTE: Please consult your healthcare professional or physician before use. Soliqua 100/33 is not for the treatment of diabetic ketoacidosis and should not be used in combination with other GLP-1 receptor agonists. Be aware of signs of hypoglycemia and monitor your blood glucose levels regularly as advised by your medical team. Seek immediate medical attention if you experience signs of severe hypersensitivity, persistent abdominal pain, or other serious adverse symptoms.